Therapeutic approaches to acquired von Willebrand syndrome

Bibliography

• SIMONE JV, CORNET JA, ABILDGAARD CF: Acquired von Willebrand's syndrome in systemic lupus erythema-tosus. Blood (1968) 31:806–812.
   PubMed Web of Science ®Google Scholar
• MANNUCCI PM, MART D: Antibodies to Factor VIII/von Willebrand factor in congenital and acquired von Willebrand's disease. Prog. Clin. Biol. Res. (1984) 150:109–122.
   PubMedGoogle Scholar
• ••This is the first review article which evaluate the incidence ofanti-FVIII/VWF in AVWS.
   Google Scholar
• JAKWAY JL: Acquired von Willebrand's disease. Hematol. Oncol. Clin. North Am. (1992) 6:1409–1419.
   PubMed Web of Science ®Google Scholar
• JAKWAY JL: Acquired von Willebrand's disease in malignancy. Semin. Thromb. Hemost. (1992) 18:434–439.
   PubMed Web of Science ®Google Scholar
• RINDER MR, RICHARD RE, RINDER HM: Acquired von Willebrand's disease: a concise review. Am. J. Hematol (1997) 54:139–145.
   PubMed Web of Science ®Google Scholar
• TEFFERI A, NICHOLS WL: Acquired von Willebrand disease: concise review of occurrence, diagnosis, pathogenesis and treatment. Am. J. Med. (1997) 103:536–540.
   PubMed Web of Science ®Google Scholar
• RUGGERI ZM: Acquired abnormalities of vonWillebrand factor: facts to consider in patients with unexpected bleeding. J. Lab. Clin. Med. (1993) 121:377–379.
   PubMed Web of Science ®Google Scholar
• VAN GENDEREN PJJ, MICHIELS JJ: Acquired vonWillebrand disease. Baillieres Clin. Haematol. (1998) 319–330.
   PubMed Web of Science ®Google Scholar
• FEDERICI AB, RAND JH, MANCINI V, BUCCIARELLI P, MANNUCCI PM: Diagnosis and therapy of Acquired von Willebrand Syndrome (AvWS): report on 211 cases of the International Registry of AvWS. Blood. (1998) 92:556a.
   Web of Science ®Google Scholar
• ••This is the first report of a retrospective analysis of cases withAVWS.
   Google Scholar
• FEINSTEIN DI, GREEN D, FEDERICI AB, GOODNIGHT SH:Diagnosis and management of patients with spontane-ously acquired inhibitors of coagulation. Hematology Amercian Society of Hematology Education Program Book (1999):192–208.
   Google Scholar
• ZETTERVALL 0, NILSSON IM: Acquired von Willebrand'sdisease caused by a monoclonal antibody. Acta Merl. Scand (1978) 204:521–528.
   PubMed Web of Science ®Google Scholar
• •This is one of the first reports of a method for anti-FVIIINWF inhibitor assays.
   Google Scholar
• FRICKE WA, BRINKHOUS KM, GARRIS JB, ROBERTS HR: Comparison of inhibitory and binding characteristics of an antibody causing acquired von Willebrand syndrome: an assay for von Willebrand factor binding by antibody. Blood (1985) 66:562–569.
   PubMed Web of Science ®Google Scholar
• •This is an improved method to search for anti-FVIII/VWF inhibitor.
   Google Scholar
• VAN GENDEREN PJJ, VINK T, MICHIELS JJ, VAN'T VEERMB, SIXMA JJ,VAN VLIET HHDM: Acquired von Willebrand disease caused by an autoantibody selectively inhibiting the binding of von Willebrand factor to collagen. Blood (1994) 84:3378–3384.
   PubMed Web of Science ®Google Scholar
• MOHRI H, MOTOMURA S, KANAMORI H, et al.: Clinical significance of inhibitors in acquired von Willebrand syndrome. Blood (1998) 91:3623–3629.
   Google Scholar
• ••This is a recent survey on the clinical sIgnificance ofinhibitor on AVWS.
   Google Scholar
• VAN GENDEREN PJJ, BOERTJES RC, VAN MOURIK JA: Quantitative analysis of von Willebrand factor and its propeptide in plasma in acquired von Willebrand syndrome. Thromb. Haemostas. (1998) 80:495–498.
   PubMed Web of Science ®Google Scholar
• •This is a proposed method to distinguish AVWS from congenital VWD.
   Google Scholar
• MOHRI H, HISANAGA S, MISHIMA A, FUJIMOTO S, UEZONO S,OKUBO T: Autoantibody inhibits binding of von Willebrand factor to glycoprotein lb and collagen in multiple myeloma: recognition sites present on the Al loop and A3 domains of von Willebrand factor. Blood Coagul. Fibrinolysis (1998) 9:91–97.
   PubMed Web of Science ®Google Scholar
• VIALLARD J-F, PELLEGRIN JL, VERGNES C et al.: Threecases of acquired von Willebrand disease associated with systemic lupus erythematosus. Br. J. Haematol. (1999) 105:532–537.
   PubMed Web of Science ®Google Scholar
• SMITH SRAUGER MJ: Hypothyroidism and von Willebrand's disease [letter]. Lancet (1987) 1:1314.
   PubMedGoogle Scholar
• ATTIVISSIMO LA, LICHTMAN SM, KLEIN I: Acquired vonWillebrand's syndrome causing a hemorrhagic diathesis in a patient with hypothyroidism. Thyroid (1995) 5:399–401.
   PubMed Web of Science ®Google Scholar
• MANNUCCI PM, LOMBARDI R, BADER R et al.: Studies of the pathophysiology of acquired von Willebrand disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies. Blood (1984) 64:614–621.
   PubMed Web of Science ®Google Scholar
• ••This is an important article describing pathophysiology ofAVWS with a correlation with type of treatment.
   Google Scholar
• BUDDE U, SCHAEFER G, MUELLER N et al.: Acquired von Willebrand's disease in the myeloproliferative syndrome. Blood (1984) 64:981–985.
   PubMed Web of Science ®Google Scholar
• •This is the first report of association between AVWS and myeloproliferative disorder.
   Google Scholar
• KINOSHITA S, YOSHIOKA K, KASAHARA M et al.: Acquired von Willebrand disease after Epstein-Barr virus infection. J. Pediatr. (1991) 119:595–598.
   PubMed Web of Science ®Google Scholar
• CARTER C, BOUGHTON BJ: Acquired von Willebrand'sdisease in myeloproliferative syndrome:spontaneous remission during pregnancy. Thromb. Haemost. (1992) 67:387–388.
   PubMed Web of Science ®Google Scholar
• SCOTT JP, MONTGOMERY RR, TUBERGEN DG, HAYS T:Acquired von Willebrand's disease in association with Wilm's tumor: regression following treatment. Blood (1981) 58:665–669.
   PubMed Web of Science ®Google Scholar
• RICHARD C, SEDANO MC, CUADRADO MA, RECIO M, HERMOSA V, ZUBIZARRETA A: Acquired von Willebrand's syndrome associated with hydatid disease of the spleen-disappearance after splenec-tomy. Thromb. HaemosL (1984) 52:90–93.
   PubMed Web of Science ®Google Scholar
• FACON T, CARON C, COURTIN P et al.: Acquired Type IIvon Willebrand's disease associated with adrenal cortical carcinoma. Br. J. Haematol. (1992) 80:488–494.
   PubMed Web of Science ®Google Scholar
• GILL JC, WILSON AD, ENDRES-BROOKS J, MONTGOMERYRR: Loss of the largest von Willebrand factor multimers from the plasma of patients with congenital cardiac defects. Blood (1986) 67:758–761.
   PubMed Web of Science ®Google Scholar
• ANDERSON RP, MCGRATH K, STREET A: Reversal of aortic stenosis, bleeding gastrointestinal angiodys-plasia and von Willebrand syndrome by aortinc valve replacement. Lancet (1996) 347:689–690.
   PubMed Web of Science ®Google Scholar
• DURAN-SAUREZ JR, PICO M, ZUAZU J, CORTES M, MONASTERIO J, TRINGINER J: Acquired von Willebrand's disease caused by a chronic granulocytic leukemia. Br. J. Haematol (1981) 48:772.
   Web of Science ®Google Scholar
• TRAN TC, MANNUCCI PM, SCHNEIDER P, FEDERICI AB,BACHMANN F: Profound alterations of the multimeric structure of von Willebrand factor in a patient with malignant lymphoma. Br. J. Haematol. (1985) 61:307–314.
   PubMed Web of Science ®Google Scholar
• MURAKAWA M, OKAMURA T, TSUTSUMI K et al. Acquired von Willebrand's disease in association with Essential Thrombocythemia: regression following treatment. Acta Haematol. (1992) 87:83–87.
   PubMed Web of Science ®Google Scholar
• BUDDE U, VAN GENDEREN PJJ: Acquired von Willebrand disease in patients with high platelet counts. Sem. Thromb. Hemost. (1997) 23:425–431.
   PubMed Web of Science ®Google Scholar
• JOIST JH, COWAN JF, ZIMMERMAN TS: Acquired von Willebrand's disease: Evidence for a quantitative and qualitative Factor VIII disorder. N Engl. J. Med. (1978) 298:988–991.
   PubMed Web of Science ®Google Scholar
• DALTON RG, DEWAR MS, SAVIDGE GF et al: Hypothy-roidism as a cause of acquired von Willebrand's disease. Lancet (1987) 1:1007–1009.
   PubMed Web of Science ®Google Scholar
• DALRYMPLE-HAY M, AITCHISON R, COLLINS P et al.Hydroxyethyl starch induced acquired von Willebrand's disease. Clin. Lab. Haematol. (1992) 14:209–211.
   PubMedGoogle Scholar
• CASTAMAN G, LATTUADA A, MANNUCCI PM, RODEGHIERO F: Characterization of two cases of acquired transitory von Willebrand syndrome with ciprofloxacin: evidence for heightened proteolysis of von Willebrand factor. Am. J. Hematol. (1995) 49:83–86.
   PubMed Web of Science ®Google Scholar
• INBAL A, BANK I, ZIVELIN A: Acquired von Willebranddisease in a patient with angiodysplasia resulting from immune-mediated clearance of von Willebrand factor. Br. J. Haematol. (1999) 96:179–182.
   Web of Science ®Google Scholar
• FEDERICI AB, STABILE F, CASTAMAN G, CANCIANI MT, MANNUCCI PM: Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches. Blood (1998) 92:2707–2711.
   PubMed Web of Science ®Google Scholar
• ••This is the first report describing a clinical trial in 10 patientswith AVWS.
   Google Scholar
• MANNUCCI PM, REMUZZI G, PUSINERI F et al.:Deamino-8-n-arginine vasopressin (DDAVI) increases Factor VIII/von Willebrand factor and shortens the bleeding time in uremia. N Engli Merl. (1983) 308:8–12.
   PubMed Web of Science ®Google Scholar
• TAKAHASHI H, NAGAYAMA R, TANABE Y et al: DDAVPin acquired von Willebrand syndrome associated with multiple myeloma. Am. J. Hematol. (1986) 22:421–429.
   PubMed Web of Science ®Google Scholar
• CASTAMAN G, RODEGHIERO F, DI BONA E, RUGGERI M:Clinical effectiveness of desmopressin in a case of acquired von Willebrand's syndrome associated with benign monoclonal gammopathy. Blood (1989) 58:211–213.
   Google Scholar
• MEYER D, FROMMEL D, LARRIEU MJ, ZIMMERMAN TS: Selective absence of large forms of Factor VIII/von Willebrand factor in acquired von Willebrand's syndrome: Response to transfusion. Blood (1979) 54:600–606.
   PubMed Web of Science ®Google Scholar
• MACIK BG, GABRIEL DA, WHITE GC, HIGH K, ROBERTS HR: The use of high-dose intravenous gamma-globulin in acquired von Willebrand syndrome. Arch. Pathol Lab. Merl. (1988) 112:143–146.
   PubMed Web of Science ®Google Scholar
• DELANNOY A, SAILLEZ AC: High-dose intravenous gammaglobulin for acquired von Willebrand's disease [letter]. Br. J. Haematol. (1988) 70:387.
   PubMed Web of Science ®Google Scholar
• CASTAMAN G, TOSETTO A, RODEGHIERO F: Effective-ness of high-dose intravenous immunoglobulin in a case of acquired von Willebrand syndrome with chronic melena not responsive to desmopressin and Factor VIII concentrate. Am. J. Hematol. (1992) 41:132–136.
   PubMed Web of Science ®Google Scholar
• DELMER A, HORELLOU MH, BRECHOT JM et al.: Acquired von Willebrand disease:correction of hemostatic defect by high-dose intravenous immunoglobulins. Am. J. Hematol. (1992) 40:151–152.
   PubMed Web of Science ®Google Scholar
• ARKEL YS, LYNCH J, KAMIYAMA M: Treatment of acquired von Willebrand syndrome with intravenous immunoglobulin. Thromb. Haemost. (1994).
   Google Scholar
• HANLEY D, ARKEL YS, LYNCH J, KAMIYAMA M: Acquired von Willebrand's syndrome in association with a lupus-like anticoagulant corrected by intravenous immunoglobulin. Am. J. Hematol (1994) 46:141–146.
   PubMed Web of Science ®Google Scholar
• VAN GENDEREN PJJ, TERPSTRA W, MICHIELS JJ, KAPTEIJN L,VAN VLIET HHDM: High-dose intravenous immuno-globin delays clearance of von Willebrand factor in acquired von Willebrand disease. Thromb. HaemosL (1995) 73:891–892.
   PubMed Web of Science ®Google Scholar
• SILBERSTEIN LE, ABRAHAM J, SHATTIL SJ: The efficacy of intensive plasma exchange in acquired von Willebrand's disease. Transfusion (1987) 27:234–237.
   PubMed Web of Science ®Google Scholar
• UEHLINGER J, ROSE E, ALEDORT LM, LEMER R: Successful treatment of an acquired von Willebrand factor antibody by extracorporeal immunoadsorption [letter]. N Engl. J. Med. (1989) 320:254–255.
   PubMed Web of Science ®Google Scholar
• STEWART AK, GLYNN MF: Acquired von Willebrand disease associated with free lambda light chain monoclonal gammopathy, normal bleeding time and response to prednisone. Postgrad. Med. J. (1990) 66:560–562.
   PubMed Web of Science ®Google Scholar